Search research articles
Contact Us
Filters
Showing results (61-70 of 69) with videos related to
Page
of 7
Sort By:
You have reached the last page of results.
This site can display upto 69 results.
Immunology and Cell Biology
|
August 18, 2023
Serological assays to measure dimeric IgA antibodies in SARS-CoV-2 infections
Zihui Wei, Fiona Angrisano, Emily M Eriksson, et al.
Journal of Clinical Microbiology
|
February 1, 2019
Performance of a Novel Low-Cost, Instrument-Free Plasma Separation Device for HIV Viral Load Quantification and Determination of Treatment Failure in People Living with HIV in Malaysia: a Diagnostic Accuracy Study
Minh D Pham, Berhan A Haile, Iskandar Azwa, et al.
Thrombosis and Haemostasis
|
September 27, 2013
Non-OO blood type influences the risk of recurrent venous thromboembolism. A cohort study
Esteban Gándara, Michael J Kovacs, Susan R Kahn, et al.
The Lancet. Infectious Diseases
|
October 11, 2018
Molecular point-of-care testing for chlamydia and gonorrhoea in Indigenous Australians attending remote primary health services (TTANGO): a cluster-randomised, controlled, crossover trial
Rebecca J Guy, James Ward, Louise M Causer, et al.
Medrxiv : the Preprint Server for Health Sciences
|
July 7, 2021
Dimeric IgA is a specific biomarker of recent SARS-CoV-2 infection
Heidi E Drummer, Huy Van, Ethan Klock, et al.
Sexually Transmitted Infections
|
May 12, 2018
Molecular test for chlamydia and gonorrhoea used at point of care in remote primary healthcare settings: a diagnostic test evaluation
Louise M Causer, Rebecca J Guy, Sepehr N Tabrizi, et al.
The Lancet. Gastroenterology & Hepatology
|
September 21, 2024
Availability of point-of-care HBV tests in resource-limited settings
Daryl T Y Lau, Kathy Jackson, Camila A Picchio, et al.
JCI Insight
|
December 22, 2017
Computational analysis of antibody dynamics identifies recent HIV-1 infection
Kelly E Seaton, Nathan A Vandergrift, Aaron W Deal, et al.
Ebiomedicine
|
December 6, 2021
A point-of-care lateral flow assay for neutralising antibodies against SARS-CoV-2
Thomas S Fulford, Huy Van, Nicholas A Gherardin, et al.
Page
of 7
Search research articles
Search
Showing results (61-70 of 69) with videos related to
Sort By:
Page
of 7
You have reached the last page of results.
This site can display upto 69 results.
Immunology and Cell Biology
|
August 18, 2023
Serological assays to measure dimeric IgA antibodies in SARS-CoV-2 infections
Zihui Wei, Fiona Angrisano, Emily M Eriksson, et al.
Journal of Clinical Microbiology
|
February 1, 2019
Performance of a Novel Low-Cost, Instrument-Free Plasma Separation Device for HIV Viral Load Quantification and Determination of Treatment Failure in People Living with HIV in Malaysia: a Diagnostic Accuracy Study
Minh D Pham, Berhan A Haile, Iskandar Azwa, et al.
Thrombosis and Haemostasis
|
September 27, 2013
Non-OO blood type influences the risk of recurrent venous thromboembolism. A cohort study
Esteban Gándara, Michael J Kovacs, Susan R Kahn, et al.
The Lancet. Infectious Diseases
|
October 11, 2018
Molecular point-of-care testing for chlamydia and gonorrhoea in Indigenous Australians attending remote primary health services (TTANGO): a cluster-randomised, controlled, crossover trial
Rebecca J Guy, James Ward, Louise M Causer, et al.
Medrxiv : the Preprint Server for Health Sciences
|
July 7, 2021
Dimeric IgA is a specific biomarker of recent SARS-CoV-2 infection
Heidi E Drummer, Huy Van, Ethan Klock, et al.
Sexually Transmitted Infections
|
May 12, 2018
Molecular test for chlamydia and gonorrhoea used at point of care in remote primary healthcare settings: a diagnostic test evaluation
Louise M Causer, Rebecca J Guy, Sepehr N Tabrizi, et al.
The Lancet. Gastroenterology & Hepatology
|
September 21, 2024
Availability of point-of-care HBV tests in resource-limited settings
Daryl T Y Lau, Kathy Jackson, Camila A Picchio, et al.
JCI Insight
|
December 22, 2017
Computational analysis of antibody dynamics identifies recent HIV-1 infection
Kelly E Seaton, Nathan A Vandergrift, Aaron W Deal, et al.
Ebiomedicine
|
December 6, 2021
A point-of-care lateral flow assay for neutralising antibodies against SARS-CoV-2
Thomas S Fulford, Huy Van, Nicholas A Gherardin, et al.
Page
of 7